Regeneron Pharmaceuticals... (REGN)

NASDAQ: REGN · Real-Time Price · USD

586.85

-11.91 (-1.99%)

At close: May 01, 2025, 3:43 PM

Regeneron Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	14.2B	13.12B	12.17B	16.07B	8.5B	7.86B	6.71B	5.87B	4.86B
Cost of Revenue	1.97B	1.82B	1.56B	2.44B	1.12B	782.2M	434.1M	397.06M	299.69M
Gross Profit	12.23B	11.3B	10.61B	13.63B	7.38B	7.08B	6.28B	5.48B	4.56B
Operating Income	3.99B	4.05B	4.74B	8.95B	3.58B	2.21B	2.53B	2.08B	1.33B
Interest Income	711.4M	495.9M	160.1M	45.8M	18.5M	30.2M	n/a	n/a	n/a
Pretax Income	4.78B	4.2B	4.86B	9.33B	3.81B	2.43B	2.55B	2.08B	1.33B
Net Income	4.41B	3.95B	4.34B	8.08B	3.51B	2.12B	2.44B	1.2B	895.52M
Selling & General & Admin	2.95B	2.63B	2.12B	1.82B	1.35B	1.83B	1.56B	1.32B	1.18B
Research & Development	5.13B	4.44B	3.59B	2.91B	2.73B	3.04B	2.19B	2.08B	2.05B
Other Expenses	154.4M	n/a	-89.9M	-45.6M	-280.4M	219.3M	19.1M	-1.08M	-926K
Operating Expenses	8.24B	7.25B	5.62B	4.69B	3.8B	4.87B	3.74B	3.4B	3.23B
Interest Expense	55.2M	73M	59.4M	57.3M	56.9M	30.2M	28.2M	25.12M	7.2M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.21B	9.07B	7.18B	7.12B	4.92B	5.65B	4.18B	3.79B	3.53B
Income Tax Expense	367.3M	245.7M	520.4M	1.25B	297.2M	313.3M	109.1M	880M	434.29M
Shares Outstanding (Basic)	107.9M	106.7M	107.1M	105.7M	107.6M	109.2M	114.8M	115.9M	116.25M
Shares Outstanding (Diluted)	115.1M	113.7M	113.5M	112.2M	115.1M	114.6M	114.8M	115.91M	116.3M
EPS (Basic)	40.90	37.05	40.51	76.40	32.65	19.38	21.29	11.27	8.55
EPS (Diluted)	38.34	34.77	38.22	71.97	30.52	18.46	21.29	10.34	7.70
EBITDA	5.32B	4.69B	5.34B	9.28B	3.9B	2.42B	2.68B	2.08B	1.44B
EBIT	4.84B	4.27B	4.99B	8.99B	3.66B	2.21B	2.53B	2.1B	1.34B
Depreciation & Amortization	482.9M	421M	341.4M	286.2M	235.9M	210.3M	148.2M	145.47M	104.75M